Understanding Bladder Cancer: Symptoms, Diagnosis, Treatment, and Urology Care

Bladder cancer is a significant health concern, and understanding its symptoms, diagnosis, and treatment options is crucial for effective urology care. As a leading cause of cancer-related deaths, particularly among older adults, bladder cancer requires a comprehensive approach from symptom recognition to advanced treatment strategies. This article, based on insights from urology experts at Mayo Clinic, aims to provide an in-depth look at bladder cancer, focusing on symptoms, diagnostic procedures, treatment modalities, and the importance of specialized urology care.

Recognizing Bladder Cancer: Symptoms and Early Detection in Urology Care

Early detection of bladder cancer significantly improves treatment outcomes. Recognizing the symptoms is the first step in seeking timely urology care. One of the most common and noticeable symptoms of bladder cancer is hematuria, or blood in the urine. This can manifest as visible blood, making the urine appear pink, red, or even cola-colored. However, sometimes hematuria can be microscopic, detectable only through a urine test. It’s important to note that hematuria, whether visible or microscopic, should never be ignored and warrants immediate consultation with a urology specialist.

Beyond hematuria, other symptoms that may indicate bladder cancer and require urology care include:

• Painful urination (dysuria): A burning sensation or pain experienced during urination can be a symptom.
• Frequent urination: An increased urge to urinate more often than usual, even when the bladder is not full.
• Urgency: A sudden and intense urge to urinate, making it difficult to delay urination.
• Urinary tract infection (UTI)-like symptoms: Symptoms that mimic a UTI, such as pelvic pain, can sometimes be associated with bladder cancer.

It is important to emphasize that these symptoms are not exclusive to bladder cancer and can be caused by other conditions, such as infections, bladder stones, or benign prostatic hyperplasia (BPH) in men. However, the presence of these symptoms, especially hematuria, necessitates prompt evaluation by a urologist to rule out bladder cancer and ensure appropriate urology care. Early diagnosis is key to effective treatment and improved prognosis.

Diagnosis of Bladder Cancer: A Comprehensive Urology Care Approach

Diagnosing bladder cancer accurately and efficiently is paramount in urology care. A combination of advanced diagnostic procedures is employed to confirm the presence of cancer, determine its type and stage, and guide the treatment strategy. Urology specialists utilize several key diagnostic tools, including cystoscopy, biopsy, urine cytology, and imaging tests.

Cystoscopy: Visual Examination in Urology

Cystoscopy is a cornerstone procedure in the diagnosis of bladder cancer within urology care. This procedure involves inserting a thin, flexible tube called a cystoscope through the urethra and into the bladder. The cystoscope is equipped with a lens and light source, allowing the urologist to directly visualize the inner lining of the urethra and bladder. This visual examination helps identify any abnormal areas, tumors, or lesions that could be indicative of bladder cancer. Cystoscopy can be performed in a clinic setting or a hospital, often with local anesthesia to minimize discomfort.

Alt text: Female cystoscopy procedure in urology care, showing the insertion of a cystoscope for bladder examination.

Alt text: Male flexible cystoscopy for urological diagnosis, illustrating the examination of the urethra and bladder.

Biopsy (TURBT): Tissue Sampling for Definitive Diagnosis in Urology

If any suspicious areas are observed during cystoscopy, a biopsy is typically performed. Often conducted during the same cystoscopy procedure, this involves removing a small tissue sample from the abnormal area for microscopic examination. The most common type of biopsy for bladder cancer is Transurethral Resection of Bladder Tumor (TURBT). TURBT is not only diagnostic but can also be therapeutic for early-stage, non-muscle-invasive bladder cancer. During TURBT, specialized instruments passed through the cystoscope are used to cut away or burn away the tumor tissue. The tissue sample obtained is then sent to a pathologist who analyzes the cells to confirm the presence of cancer, determine the type of cancer cells, and assess the grade of the cancer.

Urine Cytology: Analyzing Urine for Cancer Cells in Urology

Urine cytology is another non-invasive diagnostic test used in urology care. This test involves examining a urine sample under a microscope to detect the presence of cancerous cells shed from the lining of the urinary tract. While urine cytology is less sensitive than cystoscopy and biopsy, it can be helpful in detecting high-grade bladder cancers and monitoring for recurrence after treatment. It is often used in conjunction with other diagnostic methods to provide a more comprehensive assessment.

Imaging Tests: Visualizing the Urinary Tract in Urology

Imaging tests play a crucial role in urology care for bladder cancer diagnosis, particularly in determining the extent of the disease and detecting spread to other areas. Several imaging techniques are commonly employed:

• CT Urogram: This is a specialized type of computed tomography (CT) scan that focuses on the urinary tract. A contrast dye is injected intravenously, which is then excreted by the kidneys and passes through the ureters and bladder. CT urogram provides detailed images of the kidneys, ureters, and bladder, helping to identify tumors, blockages, or other abnormalities.

• Retrograde Pyelogram: This is an X-ray exam used to visualize the upper urinary tract, specifically the ureters and kidneys. A thin catheter is inserted through the urethra and bladder, and contrast dye is injected directly into the ureters. X-ray images are then taken as the dye flows through the urinary tract, providing detailed anatomical information. Retrograde pyelogram is often used when a CT urogram is not feasible or does not provide sufficient detail.

These diagnostic procedures, when used in combination and guided by expert urology care, allow for accurate diagnosis and staging of bladder cancer, which is essential for developing an individualized treatment plan.

Staging and Grading: Key Factors in Urology Care for Bladder Cancer

Once bladder cancer is diagnosed, determining the stage and grade of the cancer is critical for guiding treatment decisions and providing accurate prognosis within urology care. Staging describes the extent of the cancer’s spread, while grading reflects how aggressive the cancer cells appear under a microscope.

Bladder Cancer Staging: Understanding the Extent of Spread in Urology

Bladder cancer staging is based on the TNM system, which considers:

• T (Tumor): Describes the depth of tumor invasion into the bladder wall. Stages range from Ta (non-invasive papillary carcinoma) to T4 (tumor invading adjacent organs).
• N (Nodes): Indicates whether the cancer has spread to regional lymph nodes. Stages range from N0 (no lymph node involvement) to N3 (distant lymph node involvement).
• M (Metastasis): Determines if the cancer has metastasized to distant sites, such as lungs, liver, or bones. M0 indicates no distant metastasis, while M1 indicates distant metastasis.

The stages of bladder cancer are summarized using Roman numerals from 0 to IV. Lower stages indicate localized cancer, while higher stages represent more advanced, widespread disease. Accurate staging is crucial for determining the appropriate treatment approach and predicting prognosis in urology care.

Bladder Cancer Grading: Assessing Cancer Cell Aggressiveness in Urology

Bladder cancer grade is determined by examining the cancer cells under a microscope. Pathologists classify bladder cancer as either low-grade or high-grade:

• Low-grade bladder cancer: Cells in low-grade tumors resemble normal bladder cells (well-differentiated). These tumors tend to grow slowly and are less likely to invade the muscle layer of the bladder.

• High-grade bladder cancer: Cells in high-grade tumors appear abnormal and poorly organized (poorly differentiated). These tumors are more aggressive, grow faster, and have a higher risk of invading the muscle layer and spreading to other parts of the body.

The grade of bladder cancer, along with the stage, is a significant factor in determining treatment strategies and predicting patient outcomes within urology care. High-grade, muscle-invasive bladder cancer typically requires more aggressive treatment than low-grade, non-muscle-invasive disease.

Bladder Cancer Treatment Options: A Urology Care Approach

Urology care for bladder cancer offers a range of treatment options tailored to the individual patient, taking into account the stage and grade of the cancer, the patient’s overall health, and personal preferences. Treatment modalities include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy, often used in combination for optimal outcomes.

Surgery for Bladder Cancer: Local and Radical Urology Interventions

Surgery is a primary treatment modality for bladder cancer in urology care. The type of surgery depends on the stage and location of the tumor. Surgical approaches range from minimally invasive procedures for early-stage cancer to more extensive operations for advanced disease.

• Transurethral Resection of Bladder Tumor (TURBT): As mentioned earlier, TURBT is used for both diagnosis and treatment of non-muscle-invasive bladder cancer. It involves removing the tumor using instruments passed through a cystoscope. TURBT is typically the first-line treatment for these early-stage cancers.

• Cystectomy: Cystectomy is the surgical removal of the bladder. It is the standard treatment for muscle-invasive bladder cancer.

  • Partial Cystectomy: Involves removing only a portion of the bladder. This may be an option in select cases where the tumor is localized to a specific area and bladder function can be preserved.

  • Radical Cystectomy: Involves removing the entire bladder, along with surrounding lymph nodes and, in men, the prostate and seminal vesicles, and in women, the uterus, ovaries, and part of the vagina. Radical cystectomy is a major surgery and requires urinary diversion to create a new way for urine to be eliminated from the body.

    Alt text: Ileal conduit surgery in urology, using a section of the small intestine to create a new pathway for urine.

    Alt text: Neobladder reconstruction in urology, creating a new bladder from the small intestine after cystectomy.

• Urinary Diversion: Following radical cystectomy, urinary diversion is necessary. Several options exist:

  • Neobladder Reconstruction: A new bladder is created from a segment of the small intestine and connected to the urethra, allowing for near-normal urination. However, it may not be suitable for all patients and can have potential complications like incontinence or difficulty emptying.

  • Ileal Conduit: A section of the small intestine is used to create a conduit, which is connected to the ureters and brought to the abdominal surface as a stoma. Urine drains continuously into an external pouch worn on the abdomen. Ileal conduit is a simpler procedure with fewer complications compared to neobladder.

  • Continent Urinary Reservoir: A pouch is created inside the body from a segment of the intestine to store urine. The patient needs to catheterize through a stoma on the abdomen several times a day to drain the urine.

Chemotherapy for Bladder Cancer: Systemic and Intravesical Urology Approaches

Chemotherapy uses drugs to kill cancer cells and is an integral part of urology care for bladder cancer. It can be administered in different ways depending on the stage and type of cancer:

• Systemic Chemotherapy: Chemotherapy drugs are given intravenously or orally, circulating throughout the body to kill cancer cells. Systemic chemotherapy is often used for muscle-invasive bladder cancer before cystectomy (neoadjuvant chemotherapy) to improve survival rates, or after cystectomy (adjuvant chemotherapy) to eliminate any remaining cancer cells and reduce the risk of recurrence. It is also used as primary treatment for advanced or metastatic bladder cancer.

• Intravesical Chemotherapy: Chemotherapy drugs are instilled directly into the bladder through a catheter. This approach is used primarily for non-muscle-invasive bladder cancer after TURBT to destroy remaining cancer cells and prevent recurrence. Intravesical chemotherapy targets cancer cells within the bladder lining with minimal systemic side effects.

Radiation Therapy for Bladder Cancer: Targeted Energy in Urology

Radiation therapy uses high-energy rays to destroy cancer cells. In urology care for bladder cancer, radiation therapy can be used as:

• Primary Treatment: For patients who are not candidates for or choose not to undergo cystectomy, radiation therapy, often combined with chemotherapy, can be an alternative treatment option for muscle-invasive bladder cancer. This approach aims to preserve the bladder (bladder preservation).

• Adjuvant Therapy: Radiation therapy may be used after surgery in certain situations to target any remaining cancer cells and reduce the risk of recurrence.

Immunotherapy for Bladder Cancer: Harnessing the Immune System in Urology

Immunotherapy is a newer approach in urology care that boosts the body’s immune system to fight cancer cells. Different types of immunotherapy are used for bladder cancer:

• Intravesical Immunotherapy (BCG): Bacillus Calmette-Guerin (BCG) is an immunotherapy agent instilled directly into the bladder after TURBT for non-muscle-invasive bladder cancer. BCG stimulates an immune response in the bladder, targeting and destroying cancer cells. Intravesical BCG is a standard treatment for high-risk non-muscle-invasive bladder cancer.

• Systemic Immunotherapy (Immune Checkpoint Inhibitors): These drugs are given intravenously and work by blocking proteins called checkpoints that prevent the immune system from attacking cancer cells. Immune checkpoint inhibitors are used to treat advanced or metastatic bladder cancer, particularly in patients who have progressed after chemotherapy.

Targeted Therapy for Bladder Cancer: Precision Urology Oncology

Targeted therapy drugs specifically target vulnerabilities in cancer cells. In urology care for bladder cancer, targeted therapy may be an option for advanced bladder cancer when other treatments have not been effective. Genetic testing of the tumor cells may be performed to identify specific targets and determine if targeted therapy is likely to be beneficial.

Bladder Preservation: A Multimodal Urology Approach

Bladder preservation is a treatment strategy that aims to treat muscle-invasive bladder cancer without removing the bladder. Trimodality therapy is a common bladder preservation approach, combining TURBT, chemotherapy, and radiation therapy. This approach is considered for selected patients who are motivated to preserve bladder function and are closely monitored for recurrence.

Post-Treatment Urology Care: Follow-up and Monitoring

Following bladder cancer treatment, ongoing urology care and surveillance are essential due to the risk of recurrence. Regular follow-up appointments are crucial to monitor for any signs of cancer recurrence and manage any long-term side effects of treatment.

Cystoscopy is a key component of follow-up, typically performed every 3 to 6 months for the first few years after treatment, and then annually if no recurrence is detected. The frequency of follow-up cystoscopies and other tests, such as urine cytology and imaging, depends on the stage and grade of the original cancer and the type of treatment received.

Patients are encouraged to be vigilant about any new or recurring symptoms, such as hematuria, urinary frequency, or pain, and report them promptly to their urology care team. Early detection of recurrence allows for timely intervention and improved outcomes.

Coping and Support: Holistic Urology Care for Bladder Cancer Patients

Living with bladder cancer can be emotionally challenging. Urology care extends beyond medical treatment to encompass coping and support strategies. Patients may experience anxiety, fear of recurrence, and concerns about body image and quality of life, especially after radical surgery and urinary diversion.

Support groups and counseling services can provide valuable emotional support and practical advice. Connecting with other bladder cancer survivors can help patients feel less alone and learn from others’ experiences.

Adopting a healthy lifestyle, including a balanced diet, regular exercise, and stress management techniques, can also improve overall well-being and coping abilities. Open communication with the urology care team and loved ones is essential for addressing concerns and making informed decisions throughout the cancer journey.

Preparing for Your Urology Appointment

If you are experiencing symptoms suggestive of bladder cancer or have been referred to a urologist for evaluation, being well-prepared for your appointment can make the consultation more effective. Consider the following tips:

• Document your symptoms: Write down all symptoms you have been experiencing, including when they started, how frequent they are, and any factors that make them better or worse.

• List your medical history: Prepare a list of your past medical conditions, surgeries, medications, allergies, and family history of cancer.

• Prepare questions: Write down questions you want to ask your urologist. Some example questions include:

  • What are the possible causes of my symptoms?
  • What tests will I need?
  • If I have bladder cancer, what are the stage and grade?
  • What are my treatment options?
  • What are the potential side effects of treatment?
  • What is the long-term prognosis?
  • Are there any support resources available?

• Bring a companion: If possible, bring a family member or friend to your appointment. They can provide emotional support, help you remember information, and take notes.

By actively participating in your urology care and being well-informed, you can work collaboratively with your medical team to achieve the best possible outcomes in your bladder cancer journey.

More Information

Request an appointment

Clinical trials

Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.

Coping and support

Living with the concern that your bladder cancer may recur can leave you feeling as if you have little control over your future. But while there’s no way to ensure that your bladder cancer won’t recur, you can take steps to manage the stress.

Over time you’ll find what works for you, but until then, you might:

• Get a schedule of follow-up tests and go to each appointment. When you finish bladder cancer treatment, ask your doctor to create a personalized schedule of follow-up tests. Before each follow-up cystoscopy exam, expect to have some anxiety. You may fear that cancer has come back or worry about the uncomfortable exam. But don’t let this stop you from going to your appointment. Instead, plan ways to cope with your concerns. Write your thoughts in a journal, talk with a friend or use relaxation techniques, such as meditation.
• Take care of yourself so that you’re ready to fight cancer if it comes back. Take care of yourself by adjusting your diet to include plenty of fruits, vegetables and whole grains. Exercise for at least 30 minutes most days of the week. Get enough sleep so that you wake feeling rested.
• Talk with other bladder cancer survivors. Connect with bladder cancer survivors who are experiencing the same fears you’re feeling. Contact your local chapter of the American Cancer Society to ask about support groups in your area.

Preparing for your appointment

Start by seeing your family doctor if you have any signs or symptoms that worry you, such as blood in your urine. Your doctor may suggest tests and procedures to investigate your signs and symptoms.

If your doctor suspects that you may have bladder cancer, you may be referred to a doctor who specializes in treating diseases and conditions of the urinary tract (urologist). In some cases, you may be referred to other specialists, such as doctors who treat cancer (oncologists).

Because there’s often a lot of information to discuss, it’s a good idea to be well prepared. Here’s some information to help you get ready, and what to expect from your doctor.

What you can do

• Be aware of any pre-appointment restrictions. When you make the appointment, ask if there’s anything you need to do in advance, such as restrict your diet.
• Write down any symptoms you’re experiencing, including any that seem unrelated to the reason for which you scheduled the appointment.
• Write down key personal information, including any major stresses or recent life changes.
• Make a list of all medications, vitamins or supplements that you’re taking along with dosages.
• Consider taking a family member or friend along. Sometimes it’s difficult to remember all of the information provided during an appointment. Someone who accompanies you may remember something that you missed or forgot.
• Write down questions to ask your doctor.

Preparing a list of questions can help you make the most of your time with your doctor. For bladder cancer, some basic questions to ask include:

• Do I have bladder cancer or could my symptoms be caused by another condition?
• What is the stage of my cancer?
• Will I need any additional tests?
• What are my treatment options?
• Can any treatments cure my bladder cancer?
• What are the potential risks of each treatment?
• Is there one treatment that you feel is best for me?
• Should I see a specialist? What will that cost, and will my insurance cover it?
• Is there a generic alternative to the medicine you’re prescribing me?
• Are there brochures or other printed material that I can take with me? What websites do you recommend?
• What will determine whether I should plan for a follow-up visit?

In addition to the questions that you’ve prepared to ask your doctor, don’t hesitate to ask other questions that occur to you.

What to expect from your doctor

Your doctor is likely to ask you a number of questions. Being ready to answer them may allow time later to cover other points you want to address. Your doctor may ask:

• When did you first begin experiencing symptoms?
• Have your symptoms been continuous or occasional?
• How severe are your symptoms?
• What, if anything, seems to improve your symptoms?
• What, if anything, appears to worsen your symptoms?

By Mayo Clinic Staff

Bladder cancer care at Mayo Clinic

Request an appointment

Symptoms & causesDoctors & departments

March 29, 2024

Print

Bladder Cancer Discussions

Colleen Young, Connect Director Bladder Cancer Group: Introduce yourself and connect with others 197 Replies Wed, Feb 19, 2025

chevron-right

Anyone had gemcitabine and docetaxel for Bladder Cancer? 47 Replies Sat, Feb 15, 2025

chevron-right

CT scan showed 2.9 cm mass and maybe an enlarged lymph node 20 Replies Thu, Feb 06, 2025

chevron-right

See more discussions

1. AskMayoExpert. Bladder cancer (adult). Mayo Clinic; 2018.
2. Bladder cancer. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed April 1, 2020.
3. Partin AW, et al., eds. Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed April 1, 2020.
4. Bladder cancer treatment (PDQ). National Cancer Institute. https://www.cancer.gov/types/bladder/patient/bladder-treatment-pdq. Accessed April 8, 2020.
5. What is retrograde pyelography? Urology Care Foundation. https://www.urologyhealth.org/urologic-conditions/retrograde-pyelography. Accessed April 15, 2020.
6. AskMayoExpert. Urinary diversion. Mayo Clinic; 2019.
7. Warner KJ. Allscripts EPSi. Mayo Clinic. Jan. 22, 2020.

Related

Associated Procedures

News from Mayo Clinic

Products & Services

[

Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida, and Mayo Clinic in Phoenix/Scottsdale, Arizona, have been recognized among the top Cancer hospitals in the nation for 2024-2025 by U.S. News & World Report.

Learn more about this top honor ](/about-mayo-clinic/quality/rankings)